IONS IONIS PHARMACEUTICALS INC Product Launches 8-K Filing 2024 - Positive Results Announcement Ionis Pharmaceuticals announced positive results from studies of donidalorsen in patients with hereditary angioedema (HAE).Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC